These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8916010)

  • 41. Norfloxacin and silver-norfloxacin as topical antimicrobial agents: results of in vitro susceptibility testing against bacteria and Candida sp isolated from burn patients.
    Holder IA; Knoll CA; Wesselman J
    J Burn Care Rehabil; 1986; 7(6):479-83. PubMed ID: 3429479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of rufloxacin and norfloxacin effects on faecal flora.
    Marco F; Giménez MJ; Jiménez de Anta MT; Marcos MA; Salvá P; Aguilar L
    J Antimicrob Chemother; 1995 Jun; 35(6):895-901. PubMed ID: 7559202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics, pharmacokinetic-pharmacodynamic relationship, and withdrawal period of amoxicillin sodium in olive flounder (Paralichthys olivaceus).
    Park JY; Awji EG; Suh JW; Park SC
    Xenobiotica; 2016; 46(6):522-9. PubMed ID: 26407038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of norfloxacin in dogs after single intravenous and single and multiple oral administrations of the drug.
    Brown SA; Cooper J; Gauze JJ; Greco DS; Weise DW; Buck JM
    Am J Vet Res; 1990 Jul; 51(7):1065-70. PubMed ID: 2389884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Temperature-dependent viral replication and antiviral apoptotic response in viral haemorrhagic septicaemia virus (VHSV)-infected olive flounder (Paralichthys olivaceus).
    Avunje S; Kim WS; Oh MJ; Choi I; Jung SJ
    Fish Shellfish Immunol; 2012 Jun; 32(6):1162-70. PubMed ID: 22484363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for active drug efflux in fluoroquinolone resistance in Clostridium hathewayi.
    Rafii F; Park M; Wynne R
    Chemotherapy; 2005 Aug; 51(5):256-62. PubMed ID: 16088123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and pharmacodynamics of newer fluoroquinolones.
    Stein GE
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S19-24. PubMed ID: 8953102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Intraocular penetration of a new quinolone in humans: pefloxacin].
    Bron A; Talon D; Delbosc B; Estavoyer JM
    Bull Soc Ophtalmol Fr; 1987 Nov; 87(11):1261-2, 1265-8. PubMed ID: 3482788
    [No Abstract]   [Full Text] [Related]  

  • 49. [Determination of norfloxacin, an active dissociation product of silver norfloxacin, in guinea pig plasma and tissue by high performance liquid chromatography with column-switching].
    Liu LL; Cheng M; Gao S
    Yao Xue Xue Bao; 1994; 29(7):539-43. PubMed ID: 7976359
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decreased erythrocyte penetration of pefloxacin in cirrhotic patients.
    Silvain C; Breux JP; Rochard E; Bouquet S; Becq-Giraudon B; Beauchant M
    J Antimicrob Chemother; 1987 Aug; 20(2):290-2. PubMed ID: 3478331
    [No Abstract]   [Full Text] [Related]  

  • 51. [Norfloxacin: more than 20 years of clinical use, the results and place among fluoroquinolones in modern chemotherapy for infections].
    Padeĭskaia EN
    Antibiot Khimioter; 2003; 48(9):28-36. PubMed ID: 15002177
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacokinetics and tissue residues of pefloxacin and its metabolite norfloxacin in broiler chickens.
    Pant S; Rao GS; Sastry KV; Tripathi HC; Jagmohan ; Malik JK
    Br Poult Sci; 2005 Oct; 46(5):615-20. PubMed ID: 16359117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunoglobulin Tau Heavy Chain (IgT) in Flounder, Paralichthys olivaceus: Molecular Cloning, Characterization, and Expression Analyses.
    Du Y; Tang X; Zhan W; Xing J; Sheng X
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic dose urinary and serum pharmacokinetics of norfloxacin in the elderly.
    Kelly JG; Deaney NB; Lavan J; Noel J
    Br J Clin Pharmacol; 1988 Dec; 26(6):787-90. PubMed ID: 3242584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Corneal penetration of simultaneously applied topical levofloxacin, norfloxacin and lomefloxacin in human eyes.
    Yamada M; Ishikawa K; Mochizuki H; Kawai M
    Acta Ophthalmol Scand; 2006 Apr; 84(2):192-6. PubMed ID: 16637835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safety.
    Rodvold KA; Piscitelli SC
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S192-9. PubMed ID: 8399914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum and tissue fluid norfloxacin concentrations after oral administration of the drug to healthy dogs.
    Walker RD; Stein GE; Budsberg SC; Rosser EJ; MacDonald KH
    Am J Vet Res; 1989 Jan; 50(1):154-7. PubMed ID: 2919820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impaired TLR2 and TLR7 response in olive flounder infected with viral haemorrhagic septicaemia virus at host susceptible 15 °C but high at non-susceptible 20 °C.
    Avunje S; Oh MJ; Jung SJ
    Fish Shellfish Immunol; 2013 May; 34(5):1236-43. PubMed ID: 23462148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
    Akkan AG; Mutlu I; Ozyazgan S; Gök A; Yigit U; Ozüner Z; Senses V; Pekel H
    Int J Clin Pharmacol Ther; 1997 May; 35(5):214-7. PubMed ID: 9174877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.